Baseline and follow-up data for non–alendronate and alendronate patients.

Abbreviations: BMD, bone mineral density; BUN, blood urea nitrogen; C-Ca, serum corrected calcium; Cr, blood creatinine; CMV, cytomegalovirus; DM, diabetes mellitus; FN, femoral neck; H, hip; HBV, hepatitis B virus; HCV, hepatitis C virus; LS, lumbar spine; NS, not significant (p>0.05); P, serum inorganic phosphate; T, number of standard deviations above or below mean BMD of sex-matched young adults; TC, serum total cholesterol; TG, serum triglyceride. NS*, no significance (p>0.05) between non-alendronate patients and alendronage patients. NS§, no significance (p>0.05) of difference values between non-alendronate patients and alendronage patients. At follow-up, LS-BMD was significantly increased in the alendronate and non-alendronate groups (p